Stonegate Capital Partners Updates Coverage on Aquafil S.p.A (BIT: ECNL) 2Q26
Download Report Here Aquafil’s 2Q26 results continued to demonstrate the benefit of the Company’s lower fixed-cost base despite a sharp increase in raw material and transportation costs. Revenue declined 1.0% y/y to €135.7M and EBITDA declined 2.5% to €20.7M, while the 15.3% EBITDA margin remained broadly stable as contractual pricing adjustments lagged the cost increase. […]
Stonegate Capital Partners Updates Coverage on Heliostar Metals Ltd (TSXV: HSTR) 26Q2
Download Report Here Heliostar’s 2Q26 results strengthened the operating cash-flow bridge to its growth portfolio, with record production of 14,803 gold ounces, $56.5M of revenue and $31.1M of mine operating earnings, while cash increased to $43.0M despite the initial $10M Goldstrike payment. San Agustin reached steady-state production and La Colorada continues to transition toward injection […]
Stonegate Capital Partners Updates Coverage on Park-Ohio Holdings Corp. (NASDAQ:PKOH) 2Q26
Download Report Here PKOH’s 2Q26 results showed broad-based operating improvement, with revenue of $440.1M, adjusted EBITDA of $38.8M, and adjusted EPS of $0.93 all ahead of Stonegate and consensus estimates. Revenue increased 10% y/y across all three segments, while gross margin expanded 90 bps to 17.9%, its highest level since 2013, driven by stronger volume […]
Stonegate Capital Partners Updates Coverage on Materion Corp (NYSE: MTRN) 2Q26
Download Report Here Materion’s 2Q26 results strengthened the earnings outlook, with record VA sales, adjusted EBITDA, and adjusted EPS supported by a rebound in Performance Materials and sustained profitability across Electronic Materials and Precision Optics. Backlog increased approximately 30% y/y, while broad-based order growth across defense, space, and semiconductors provides improved demand visibility over the […]
Stonegate Capital Partners Updates Coverage on Metallus Inc (NYSE: MTUS) 2Q26
Download Report Here MTUS’ 2Q26 results strengthened the forward earnings profile, with shipments exceeding prior guidance and favorable price/mix driving sequential revenue and adjusted EBITDA growth despite continued manufacturing inefficiencies. Demand visibility improved meaningfully, supported by accelerating order-book growth, record aerospace and defense shipments, and industrial backlog extending production visibility through late 4Q26. The principal […]
Stonegate Capital Partners Updates Coverage on Stepan Company (NYSE: SCL) 2Q26
SCL delivered a strong 2Q26 rebound, with net sales increasing 15% year-over-year to $684.1M and adjusted EBITDA rising 45% to $74.4M, driven by a recovery in the Surfactants segment, organic volume growth, pricing improvements, and ongoing Project Catalyst cost savings. While results exceeded expectations, management cautioned that 2Q should not be viewed as a sustainable […]
Stonegate Updates Coverage on Burcon Nutrascience Corporation (TSX: BU) 4Q26
Burcon has moved from commissioning and into early utilization, with growing customer volume setting up better fixed-cost absorption at Galesburg. The Company completed commissioning and launched commercial production across Peazazz pea protein, Puratein C canola protein, and FavaPro fava protein in FY26. Revenue increased sequentially to $0.83M in 4Q26 from $0.74M in 3Q26, and management […]